M. Deguise

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Marc‐olivier Deguise, M.-o. Deguise, M. Deguise, Marc-olivier Deguise, Marc-oliver Deguise, M Deguise
Publication record
43 papers · 604 citations · H-index 13

PAPERS

The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi‐Prong Approach for a Heterogeneous Disease
20250 citationsauthor #1
NIPPV vs CPAP: Lessons from meta-analyses.
20253 citationsauthor #1
Bullying experiences of youth with neuromuscular disorders and their well-being: A survey study.
20250 citationsauthor #2
Correction: Abstracts from the 6th congress of Joint European Neonatal Societies: oral presentations
20250 citationsauthor #27
Cell-based therapies in preclinical models of necrotizing enterocolitis: a systematic review and meta-analysis
20253 citationsauthor #3
Skeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy
20254 citationsauthor #6
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs.
20250 citationsauthor #3
Rectosigmoid intussusception presenting as rectal prolapse in a premature baby: A case report
20240 citationsauthor #3
Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy
20248 citationsauthor #7
SMN depletion impairs skeletal muscle formation and maturation in a mouse model of SMA
20242 citationsauthor #3
Congenital dyserythropoietic anemia type IV in the genetic era: A rare neonatal case report of rapid identification with a review of the literature
20233 citationsauthor #1
Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
20234 citationsauthor #2
Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
202311 citationsauthor #2
Suppression of the necroptotic cell death pathways improves survival in Smn2B/− mice
20229 citationsauthor #2
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy
202216 citationsauthor #2
Survival motor neuron protein deficiency alters microglia reactivity
202213 citationsauthor #3
17 Early nasal intermittent positive pressure ventilation versus early nasal continuous positive airway pressure for preterm infants
20221 citationsauthor #2
Resident Match During the COVID Pandemic: How Have Neurology Programs Adapted? – A Survey
20227 citationsauthor #4
SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease
202123 citationsauthor #1
Metabolic Dysfunction in Spinal Muscular Atrophy
202141 citationsauthor #1
Central and peripheral delivery of AAV9-SMN target different pathomechanisms in a mouse model of spinal muscular atrophy
20211 citationsauthor #2
Spinal Muscular Atrophy: Evidence of a Multi-System Disease
20200 citationsauthor #1
Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy
20209 citationsauthor #1
A mouse model for spinal muscular atrophy provides insights into non-alcoholic fatty liver disease pathogenesis
20203 citationsauthor #1
Sex Difference in a New Mild Mouse Model of Spinal Muscular Atrophy (2089)
20200 citationsauthor #1
Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy
202022 citationsauthor #1
Into the unknown
20190 citationsauthor #1
P.068 Abnormal fatty acid metabolism is a feature of spinal muscular atrophy
20190 citationsauthor #1
Impaired kidney structure and function in spinal muscular atrophy
201941 citationsauthor #4
Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
2019114 citationsauthor #1
Low fat diets increase survival of a mouse model of spinal muscular atrophy
201918 citationsauthor #1
Contributors
20190 citationsauthor #7
SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES
20180 citationsauthor #1
Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy
201711 citationsauthor #6
Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice
201762 citationsauthor #1
New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
201747 citationsauthor #1
The role of the TWEAK/Fn14 pathway in muscle pathology in SMA
20170 citationsauthor #4
The glucocorticoid-KLF15-BCAA pathway as a novel therapeutic target for spinal muscular atrophy
20171 citationsauthor #7
Contributions of Different Cell Types to Spinal Muscular Atrophy Pathogenesis
20177 citationsauthor #1
P.119 - Abnormal fatty acid metabolism is a feature of spinal muscular atrophy
20170 citationsauthor #1
MD/PhD Training in Canada: Results from a national trainee and program director review.
201616 citationsauthor #3
Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy
201631 citationsauthor #1
Acute Stroke Research: Being Part of a Game-Changer with Dr. Dar Dowlatshahi, Scientific Director of the Ottawa Stroke Program
20150 citationsauthor #2
Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
201475 citationsauthor #2

TIMELINE

2014 75 citations

2015 0 citations

2016 47 citations

2017 128 citations

2018 0 citations

2019 173 citations

2020 34 citations

2021 65 citations

2022 46 citations

2023 18 citations

2024 10 citations

2025 10 citations

M. Deguise

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT